{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T05:13:37Z","timestamp":1774847617968,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,29]]},"DOI":"10.7759\/cureus.106089","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T03:42:56Z","timestamp":1774842176000},"source":"Crossref","is-referenced-by-count":0,"title":["Helicobacter pylori Eradication Using Empirical Therapy in Symptomatic Pediatric Patients: A Multicenter Real-World Study From Colombia"],"prefix":"10.7759","author":[{"given":"Jos\u00e9 Fernando","family":"Vera Chamorro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Zambrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constanza","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataly","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Riveros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Enr\u00edquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailim M","family":"Carias Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Higuera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Quimbayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Losada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto","family":"Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"V\u00e1squez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001594","article-title":"Joint ESPGHAN\/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents (update 2016)","volume":"64","author":"Jones NL","year":"2017","unstructured":"Jones NL, Koletzko S, Goodman K, et al.. Joint ESPGHAN\/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents (update 2016). J Pediatr Gastroenterol Nutr. 2017, 64:991-1003. 10.1097\/MPG.0000000000001594","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-012-1823-4","article-title":"Clinical practice: Helicobacter pylori infection in childhood","volume":"172","author":"Ertem D","year":"2013","unstructured":"Ertem D. Clinical practice: Helicobacter pylori infection in childhood. Eur J Pediatr. 2013, 172:1427-34. 10.1007\/s00431-012-1823-4","journal-title":"Eur J Pediatr"},{"key":"ref3","article-title":"World Health Organization. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori. Lyon: IARC 1994","author":"WHO","year":"1994","unstructured":"WHO. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori. IARC Press, Lyon; 1994. https:\/\/publications.iarc.who.int\/Book-And-Report-Series\/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazard...."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12528","article-title":"Helicobacter pylori antimicrobial resistance in a pediatric population","volume":"23","author":"Silva GM","year":"2018","unstructured":"Silva GM, Silva HM, Nascimento J, Gon\u00e7alves JP, Pereira F, Lima R. Helicobacter pylori antimicrobial resistance in a pediatric population. Helicobacter. 2018, 23:e12528. 10.1111\/hel.12528","journal-title":"Helicobacter"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002016","article-title":"Evaluation of Helicobacter pylori infection and clarithromycin resistance in strains from symptomatic Colombian children","volume":"67","author":"Rosero YL","year":"2018","unstructured":"Rosero YL, Ar\u00e9valo-Jaimes BV, Delgado MP, et al.. Evaluation of Helicobacter pylori infection and clarithromycin resistance in strains from symptomatic Colombian children. J Pediatr Gastroenterol Nutr. 2018, 67:601-4. 10.1097\/MPG.0000000000002016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref6","article-title":"Helicobacter pylori en ni\u00f1os","volume":"33","author":"Zacur M","year":"2006","unstructured":"Zacur M, Duarte D, Petit S, Ibieta F, Nunez M. Helicobacter pylori en ni\u00f1os. Pediatr (Asunci\u00f3n). 2006, 33:26-31.","journal-title":"Pediatr (Asunci\u00f3n)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.24","article-title":"The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America","volume":"109","author":"Camargo MC","year":"2014","unstructured":"Camargo MC, Garc\u00eda A, Riquelme A, et al.. The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America. Am J Gastroenterol. 2014, 109:485-95. 10.1038\/ajg.2014.24","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-016-0509-x","article-title":"Eradication of Helicobacter pylori infection","volume":"18","author":"Marcus EA","year":"2016","unstructured":"Marcus EA, Sachs G, Scott DR. Eradication of Helicobacter pylori infection. Curr Gastroenterol Rep. 2016, 18:33. 10.1007\/s11894-016-0509-x","journal-title":"Curr Gastroenterol Rep"},{"key":"ref9","article-title":"Gastric cancer: the Colombian enigma","volume":"25","author":"Correa P","year":"2010","unstructured":"Correa P, Piazuelo MB. Gastric cancer: the Colombian enigma. Rev Col Gastroenterol. 2010, 25:334-7.","journal-title":"Rev Col Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2016.03.008","article-title":"Stomach cancer burden in Central and South America","volume":"44 Suppl 1","author":"Sierra MS","year":"2016","unstructured":"Sierra MS, Cueva P, Bravo LE, Forman D. Stomach cancer burden in Central and South America. Cancer Epidemiol. 2016, 44 Suppl 1:S62-73. 10.1016\/j.canep.2016.03.008","journal-title":"Cancer Epidemiol"},{"key":"ref11","article-title":"Comparison of sequential therapy with standard triple therapy for Helicobacter pylori eradication","author":"Burbano CM","year":"2011","unstructured":"Burbano CM. Comparison of sequential therapy with standard triple therapy for Helicobacter pylori eradication. Asoc Colomb Gastroenterol. 2011, 171-7.","journal-title":"Asoc Colomb Gastroenterol"},{"key":"ref12","article-title":"Effect of sequential therapy on treatment of Helicobacter pylori infection in children","volume":"38","author":"Dehghani SM","year":"2018","unstructured":"Dehghani SM, Nazari A, Javaherizadeh H. Effect of sequential therapy on treatment of Helicobacter pylori infection in children. Rev Gastroenterol Peru. 2018, 38:128-30.","journal-title":"Rev Gastroenterol Peru"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113196660728","article-title":"Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance","volume":"20","author":"Nijevitch AA","year":"2014","unstructured":"Nijevitch AA, Idrisov B, Akhmadeeva EN, Graham DY. Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance. Curr Pharm Des. 2014, 20:4510-6. 10.2174\/13816128113196660728","journal-title":"Curr Pharm Des"},{"key":"ref14","article-title":"Helicobacter pylori: how do we treat it in 2018? (Article in Spanish)","volume":"38","author":"Otero RW","year":"2018","unstructured":"Otero RW, G\u00f3mez ZM, Otero PL, Trespalacios RA. Helicobacter pylori: how do we treat it in 2018? (Article in Spanish). Rev Gastroenterol Peru. 2018, 38:54-63.","journal-title":"Rev Gastroenterol Peru"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2223\/JPED.1772","article-title":"Furazolidone, tetracycline and omeprazole: a low-cost alternative for Helicobacter pylori eradication in children","volume":"84","author":"Machado RS","year":"2008","unstructured":"Machado RS, Silva MR, Viriato A. Furazolidone, tetracycline and omeprazole: a low-cost alternative for Helicobacter pylori eradication in children. J Pediatr (Rio J). 2008, 84:160-5. 10.2223\/JPED.1772","journal-title":"J Pediatr (Rio J)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-018-0296-y","article-title":"Helicobacter pylori infection in pediatric patients: update on diagnosis and eradication strategies","volume":"20","author":"Kotilea K","year":"2018","unstructured":"Kotilea K, Kalach N, Homan M, Bontems P. Helicobacter pylori infection in pediatric patients: update on diagnosis and eradication strategies. Paediatr Drugs. 2018, 20:337-51. 10.1007\/s40272-018-0296-y","journal-title":"Paediatr Drugs"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12414","article-title":"Helicobacter pylori infection in children","volume":"22 Suppl 1","author":"Kalach N","year":"2017","unstructured":"Kalach N, Bontems P, Raymond J. Helicobacter pylori infection in children. Helicobacter. 2017, 22 Suppl 1:10.1111\/hel.12414","journal-title":"Helicobacter"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.32641\/rchped.v91i5.2579","article-title":"Adaptation of the NASPGHAN\/ESPGHAN 2016 pediatric Helicobacter pylori guidelines to Latin American realities","volume":"91","author":"Harris PR","year":"2020","unstructured":"Harris PR, Calder\u00f3n-Guerrero OG, Vera-Chamorro JF, et al.. Adaptation of the NASPGHAN\/ESPGHAN 2016 pediatric Helicobacter pylori guidelines to Latin American realities. Andes Pediatr [Internet]. 2020, 91:809-27. 10.32641\/rchped.v91i5.2579","journal-title":"Andes Pediatr [Internet]"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/children9091391","article-title":"The effectiveness of different eradication schemes for pediatric Helicobacter pylori infection-a single-center comparative study from Romania","volume":"9","author":"Rosu OM","year":"2022","unstructured":"Rosu OM, Gimiga N, Stefanescu G, et al.. The effectiveness of different eradication schemes for pediatric Helicobacter pylori infection-a single-center comparative study from Romania. Children (Basel). 2022, 9:1391. 10.3390\/children9091391","journal-title":"Children (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0318315","article-title":"Effectiveness of first line therapy for Helicobacter pylori infection in children and adolescents: a multicenter study in the United Arab Emirates","volume":"20","author":"Al Atrash E","year":"2025","unstructured":"Al Atrash E, Azzaz A, AbdelMassih A, Bakro A, Al-Marzooq F. Effectiveness of first line therapy for Helicobacter pylori infection in children and adolescents: a multicenter study in the United Arab Emirates. PLoS One. 2025, 20:e0318315. 10.1371\/journal.pone.0318315","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.32641\/andespediatr.v94i6.4748","article-title":"Successful eradication rate of Helicobacter pylori with empirical antibiotic treatment in pediatric patients from a tertiary hospital) (Article in Spanish)","volume":"94","author":"Darritchon Lama S","year":"2023","unstructured":"Darritchon Lama S, D\u00edaz Garc\u00eda D, Toledo Cumplido M, Lucero \u00c1lvarez Y. Successful eradication rate of Helicobacter pylori with empirical antibiotic treatment in pediatric patients from a tertiary hospital) (Article in Spanish). Andes Pediatr. 2023, 94:721-8. 10.32641\/andespediatr.v94i6.4748","journal-title":"Andes Pediatr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/hel.13101","article-title":"Antimicrobial resistance of Helicobacter pylori isolated from Latin American children and adolescents (2008-2023): a systematic review","volume":"29","author":"Cabrera C","year":"2024","unstructured":"Cabrera C, Torres J, Serrano CA, et al.. Antimicrobial resistance of Helicobacter pylori isolated from Latin American children and adolescents (2008-2023): a systematic review. Helicobacter. 2024, 29:e13101. 10.1111\/hel.13101","journal-title":"Helicobacter"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-024-05833-8","article-title":"Different regimens for eradication of Helicobacter pylori infection in children: a randomized controlled trial","volume":"184","author":"Barakat SH","year":"2024","unstructured":"Barakat SH, Hanafy HM, Guimei M, Elsawy EH, Khalil AF. Different regimens for eradication of Helicobacter pylori infection in children: a randomized controlled trial. Eur J Pediatr. 2024, 184:13. 10.1007\/s00431-024-05833-8","journal-title":"Eur J Pediatr"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1909666","article-title":"Family history of gastric cancer and Helicobacter pylori treatment","volume":"382","author":"Choi IJ","year":"2020","unstructured":"Choi IJ, Kim CG, Lee JY, Kim YI, Kook MC, Park B, Joo J. Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med. 2020, 382:427-36. 10.1056\/NEJMoa1909666","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2019.04.003","article-title":"Prevalence of Helicobacter pylori infection in Latin America and the Caribbean populations: a systematic review and meta-analysis","volume":"60","author":"Curado MP","year":"2019","unstructured":"Curado MP, de Oliveira MM, de Ara\u00fajo Fagundes M. Prevalence of Helicobacter pylori infection in Latin America and the Caribbean populations: a systematic review and meta-analysis. Cancer Epidemiol. 2019, 60:141-8. 10.1016\/j.canep.2019.04.003","journal-title":"Cancer Epidemiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s40746-025-00328-6","article-title":"Helicobacter pylori in children: an individualized approach to a worldwide disease","volume":"11","author":"Mebuge DL","year":"2025","unstructured":"Mebuge DL, Noel RJ, Gold BD. Helicobacter pylori in children: an individualized approach to a worldwide disease. Curr Treat Options Peds. 2025, 11:13. 10.1007\/s40746-025-00328-6","journal-title":"Curr Treat Options Peds"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/445183-helicobacter-pylori-eradication-using-empirical-therapy-in-symptomatic-pediatric-patients-a-multicenter-real-world-study-from-colombia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T03:43:03Z","timestamp":1774842183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/445183-helicobacter-pylori-eradication-using-empirical-therapy-in-symptomatic-pediatric-patients-a-multicenter-real-world-study-from-colombia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.106089","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,29]]}}}